PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-04-23

Date Title Company
23-Apr-2026 Thermo Fisher Scientific Reports First Quarter 2026 Results Businesswire
23-Apr-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
23-Apr-2026 Worldwide Clinical Trials and Medidata Announce Strategic Partnership to Embed Medidata AI Across the Full Trial Lifecycle, Bolstering Study Execution and Delivery Excellence Worldwide Clinical Trials
23-Apr-2026 Samsung Epis Holdings Reports First Quarter 2026 Financial Results Businesswire
23-Apr-2026 Wegovy®▼ (semaglutide injection) approved by MHRA for 48-hour controlled-temperature delivery MHRA
23-Apr-2026 Last patient, last visit completed in Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA) PulseSight
23-Apr-2026 New Framework Proposes Risk-Based Governance for AI in Clinical Development Advarra
23-Apr-2026 Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026 ACCESS Newswire
23-Apr-2026 Nation's Top Medical Equipment Rental Provider Expands to Portland as Oregon Hospitals Confront Nation's Second-Tightest Bed Supply ACCESS Newswire
23-Apr-2026 University of Ottawa Heart Institute Reduces Surgical Site Infections Following Implementation of Steriwave Nasal Photodisinfection University of Ottawa Heart Institute
23-Apr-2026 Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) ACCESS Newswire
23-Apr-2026 65% of eligible lung cancer patients do not receive the most appropriate targeted therapies, Diaceutics report finds Diaceutics
23-Apr-2026 Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria Sanofi
23-Apr-2026 Santhera Appoints Orlando Oliveira as Chief Executive Officer Santhera
23-Apr-2026 Awen Oncology secures significant new funds to advance pioneering cancer therapeutics Awen Oncology
23-Apr-2026 OSE Immunotherapeutics Announces Presentation of TEDOVA Phase 2 Topline Results of Tedopi® in Ovarian Cancer at the ASCO 2026 Meeting OSE Immunotherapeutics
23-Apr-2026 Hikma reiterates full year 2026 guidance following encouraging start to the year Hikma
23-Apr-2026 ENA Respiratory Appoints Melissa Faris to Board ENA Respiratory
23-Apr-2026 Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114 ACCESS Newswire
23-Apr-2026 Epitopea Announces Approval of OVACT Clinical Trial Application for CryptiVax-1001 in Advanced High-Grade Serous Ovarian Cancer Epitopea